Concord Drugs

quarterly
yearly
ParticularsDec '23Mar '24Jun '24Sep '24Dec '24
Revenue12.6214.476.3511.8510.77
Expenses12.8815.056.3311.7810.26
EBITDA0.560.190.740.801.32
EBIT0.17-0.200.400.460.95
Profit Before Tax-0.26-0.570.020.070.52
Net Profit-0.24-0.350.010.050.22
Financial Ratios
Operating Profit Margin4.44%1.31%11.50%6.76%12.16%
Net Profit Margin-1.90%-2.42%0.16%0.42%2.04%
Earning Per Share (Diluted)-0.24-0.350.010.050.22
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.6.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ